Drug of Abuse (DOA) Testing Market Size, By Product Type (Consumable, Equipment), By Sample Type (Urine, Saliva, Hair and others), By Application/End-User (Hospitals, Laboratories, Workplace, At-Home), By Region Analysis - Global Forecast 2023-2028
The scope of the report includes a detailed study of Drug of Abuse (DOA) Testing Market with the reasons given for variations in the growth of the industry in certain regions.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
5
REPORT DESCRIPTION
Drugs of Abuse testing is clinical screening procedure to detect one or more illegal substances like drug, chemical, or plant product that is addicted to the patient. This clinical screening procedure is performed on the patient’s urine, saliva, blood, hair or sweat. Today’s modern lifestyle is pushing the adults towards DOA, and to rescue the adults from DOA the government is promoting the DOA testing. There are many certain laws to rescue DOA victims and also tract the suspect who are leading DOA market. Therefore, the drug of abuse testing market is driven with many challenges as well opportunities.
The Drug of Abuse (DOA) Testing Market is segmented on the lines of its product, application, end-user and regional. Based on product segmentation the global Drug of Abuse (DOA) Testing Market splits into consumable, equipment. Based on sample type segmentation the global Drug of Abuse (DOA) Testing Market covers Urine, Saliva, Hair and others. Based on application/end-user segmentation the global Drug of Abuse (DOA) Testing Market covers Hospitals, Laboratories, Workplace, At-Home. The Drug of Abuse (DOA) Testing Market on geographical segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographical market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Mexico, Germany, UK, France, Italy, Australia, Indonesia, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
The Global Drug of Abuse (DOA) Testing Market is shared among the major players including Abbott Laboratories, Bio-Rad Laboratories, Danaher Corporation, Express Diagnostics Int'l, Merck KGaA, Roche, Laboratory Corporation of America Holdings, Psychemedics Corporation, Siemens AG, Merck, Thermo Fisher Scientific, Quest Diagnostics. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drug of Abuse (DOA) Testing Market has been segmented as below:
Drug of Abuse (DOA) Testing Market, By Product
Drug of Abuse (DOA) Testing Market, By Sample Type
Drug of Abuse (DOA) Testing Market, By Application/End-User
Drug of Abuse (DOA) Testing Market, By Region
The report covers:
Report scope:
The scope of the report includes a detailed study of Drug of Abuse (DOA) Testing Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Bio-Rad Laboratories, Danaher Corporation, Express Diagnostics Int'l, Merck KGaA, Roche, Laboratory Corporation of America Holdings, Psychemedics Corporation, Siemens AG, Merck, Thermo Fisher Scientific, Quest Diagnostics. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.
The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
Customization:
We can offer you custom research reports as per client’s special requirements
Below are our New Reports :-
Active Pharmaceutical Ingredient (API) Market
Active Pharmaceutical Ingredients Market
Clopidol (CAS 2971-90-6) Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Government laws
4.2.2. Increase in adults with DOA
4.3. Restraints
4.3.1. Problems involved in competitive market.
4.4. Opportunities
4.5. Challenges
5. Drug of Abuse (DOA) Testing Market, By Product
5.1. Key Points
5.2. Consumable
5.3. Equipment
6. Drug of Abuse (DOA) Testing Market, By Sample type
6.1. Key Points
6.2. Urine
6.3. Saliva
6.4. Hair
6.5. Others
7. Drug of Abuse (DOA) Testing Market, By Application/End-User
7.1. Key Points
7.2. Hospitals
7.3. Laboratories
7.4. Workplace
7.5. At-Home
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Bio-Rad Laboratories
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Danaher Corporation
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Express Diagnostics Int'l
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Merck KGaA
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Roche
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Laboratory Corporation of America Holdings
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Psychemedics Corporation
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. Siemens AG
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Merck
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
9.11. Thermo Fisher Scientific
9.11.1. Company Overview
9.11.2. Product/Service Landscape
9.11.3. Financial Overview
9.11.4. Recent Developments
9.12. Quest Diagnostics
9.12.1. Company Overview
9.12.2. Product/Service Landscape
9.12.3. Financial Overview
9.12.4. Recent Developments
The Drug of Abuse (DOA) Testing Market has been segmented as below:
Drug of Abuse (DOA) Testing Market, By Product
Drug of Abuse (DOA) Testing Market, By Sample Type
Drug of Abuse (DOA) Testing Market, By Application/End-User
Drug of Abuse (DOA) Testing Market, By Region
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE